More progress defining the crosstalk between multiple myeloma and mesenchymal stem cells of the bone marrow

Leukemia and Lymphoma

Volumn 48, Issue 10, 2007, Pages 1896-1897

  Gregory, Carl A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DICKKOPF 1 PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 6; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOCRINE EFFECT; BONE ATROPHY; BONE DEVELOPMENT; BONE MARROW CELL; BONE REMODELING; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; METASTASIS; MULTIPLE MYELOMA; NOTE; OSTEOLYSIS; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; UPREGULATION;

BONE AND BONES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE PROGRESSION; HUMANS; INTERLEUKIN-6; MESODERM; MODELS, BIOLOGICAL; MULTIPLE MYELOMA; OSTEOBLASTS; SIGNAL TRANSDUCTION; STEM CELLS; T-LYMPHOCYTES; WNT PROTEINS;

EID: 35148856265     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701625115     Document Type: Note

References (10)

1. Garderet, L., Mazurier, C., Chapel, A., Ernou, I., Boutin, L. and Holy, X. (2007) Mesenchymal stem cell abnormalities in patients with multiple myeloma. Leuk Lymphoma, 48, pp. 2032-2041.
2. Arnulf, B., Lecourt, S., Soulier, J., Ternaux, B., Lacassagne, M. N. and Crinquette, A. (2007) Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma. Leukemia, 21, pp. 158-163.
3. Corre, J., Mahtouk, K., Attal, M., Gadelorge, M., Huynh, A. and Fleury-Cappellesso, S. (2007) Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia, 21, pp. 1079-1088.
4. Tian, E., Zhan, F., Walker, R., Rasmussen, E. and Barlogie, B. (2003) The role of Wnt signaling antagonist Dkk-1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med, 349, pp. 2483-2494.
5. Gunn, W. G., Conley, A., Deininger, L., Olson, S. D., Prockop, D. J. and Gregory, C. A. (2005) A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and IL-6: A potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells, 24, pp. 986-991.
6. Hall, C. L., Kang, S., MacDougald, O. A. and Keller, E. T. (2006) Role of Wnts in prostate cancer bone metastases. J Cell Biochem, 97, pp. 661-672.
7. Yaccoby, S., Ling, W., Zhan, F., Walker, R., Barlogie, B. and Shaughnessy, J. D. (2007) Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo. Blood, 109, pp. 2106-2111.
8. Gregoretti, M. G., Gottardi, D., Ghia, P., Bergui, L., Merico, F. and Marchisio, P. C. (1994) Characterization of bone marrow stromal cells from multiple myeloma. Leuk Res, 18, pp. 675-682.
9. Wallace, S. R., Oken, M. M., Lunetta, K. L., Panoskaltsis-Mortari, A. and Masellis, A. M. (2001) Abnormalities of bone marrow mesenchymal cells in multiple myeloma patients. Cancer, 91, pp. 1219-1230.
10. Grotewold, L. and Rüther, U. (2002) The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death. EMBO J, 21, pp. 966-975.